Northern Trust
GOSS icon

Northern Trust’s Gossamer Bio GOSS Stock Holding History

Northern Trust’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.5K Sell
458,498
-950,462
-67% -$265K ﹤0.01% 4188
2026
Q1 		$463K Sell
1,408,960
-7,580
-0.5% -$11.9K ﹤0.01% 3643
2025
Q4 		$4.39M Sell
1,416,540
-78,863
-5% -$225K ﹤0.01% 2548
2025
Q3 		$3.93M Sell
1,495,403
-24,723
-2% -$54.5K ﹤0.01% 2641
2025
Q2 		$1.87M Buy
1,520,126
+1,110,010
+271% +$1.21M ﹤0.01% 3028
2025
Q1 		$451K Sell
410,116
-1,210
-0.3% -$1.4K ﹤0.01% 3617
2024
Q4 		$372K Buy
411,326
+626
+0.2% +$536 ﹤0.01% 3758
2024
Q3 		$405K Sell
410,700
-30,315
-7% -$29.2K ﹤0.01% 3640
2024
Q2 		$397K Buy
441,015
+54,457
+14% +$40.7K ﹤0.01% 3593
2024
Q1 		$456K Sell
386,558
-56,228
-13% -$61.9K ﹤0.01% 3589
2023
Q4 		$404K Buy
442,786
+6,026
+1% +$4.45K ﹤0.01% 3612
2023
Q3 		$364K Buy
436,760
+240,395
+122% +$277K ﹤0.01% 3602
2023
Q2 		$236K Sell
196,365
-412,469
-68% -$514K ﹤0.01% 3761
2023
Q1 		$767K Sell
608,834
-50,853
-8% -$97.3K ﹤0.01% 3308
2022
Q4 		$1.43M Sell
659,687
-14,284
-2% -$118K ﹤0.01% 3147
2022
Q3 		$8.07M Buy
673,971
+46,896
+7% +$582K ﹤0.01% 2143
2022
Q2 		$5.25M Buy
627,075
+34,900
+6% +$270K ﹤0.01% 2479
2022
Q1 		$5.14M Sell
592,175
-5,914
-1% -$57K ﹤0.01% 2572
2021
Q4 		$6.76M Sell
598,089
-2,348
-0.4% -$27.9K ﹤0.01% 2514
2021
Q3 		$7.55M Sell
600,437
-7,769
-1% -$71.5K ﹤0.01% 2472
2021
Q2 		$4.94M Buy
608,206
+5,066
+0.8% +$43.9K ﹤0.01% 2846
2021
Q1 		$5.58M Sell
603,140
-51,796
-8% -$522K ﹤0.01% 2679
2020
Q4 		$6.33M Sell
654,936
-22,613
-3% -$223K ﹤0.01% 2538
2020
Q3 		$8.41M Buy
677,549
+33,600
+5% +$445K ﹤0.01% 2207
2020
Q2 		$8.37M Buy
643,949
+124,731
+24% +$1.57M ﹤0.01% 2210
2020
Q1 		$5.27M Sell
519,218
-472
-0.1% -$6.16K ﹤0.01% 2274
2019
Q4 		$8.12M Buy
519,690
+11,086
+2% +$223K ﹤0.01% 2314
2019
Q3 		$8.54M Buy
508,604
+328,788
+183% +$6.54M ﹤0.01% 2245
2019
Q2 		$3.99M Buy
179,816
+16,340
+10% +$313K ﹤0.01% 2675
2019
Q1 		$3.54M Buy
+163,476
New +$3.41M ﹤0.01% 2753

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Northern Trust's GOSS Position: Q2 2026 in Review

Northern Trust reduced its Gossamer Bio (GOSS) stake by 67% in Q2 2026, selling an estimated $265K and leaving 458,498 shares worth $75.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4188.

Northern Trust first reported a position in GOSS in Q1 2019 and has held it in 30 quarters since. The position peaked at $8.54M in Q3 2019. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Northern Trust held 458,498 shares of Gossamer Bio worth $75.5K as of Q2 2026.
  • Northern Trust sold 950,462 Gossamer Bio shares in Q2 2026, an estimated $265K.
  • Gossamer Bio made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4188 holding.
  • Northern Trust first reported a position in Gossamer Bio in Q1 2019 and has held it in 30 quarters since.
  • Northern Trust's Gossamer Bio position peaked at $8.54M in Q3 2019.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.